Please provide your email address to receive an email when new articles are posted on . There is no current treatment for children with APDS aged 4 to 11 years. Diagnostic delays have a mean of 7 ...
A Prescription Drug User Fee Act target date of January 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug ...
If approved, leniolisib will be first and only treatment indicated for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rareprimary immunodeficiency Decision based on ...
Discount Weather Tech Genuine Toyota Tacoma All-Weather Floor Liners (2018-2021 Double Cab) – 3-Piece Set, Black Rubber Oem ...
A teenager who lost four family members to a rare genetic condition has become the first person in Europe to receive a “life-changing” drug after it was approved for use on the NHS. Mary Catchpole, 19 ...
A teenager who lost her mother, aunt and uncle to a genetic condition is the first person in Europe to receive a "life-changing" drug. Mary Catchpole, 19, from Great Yarmouth, suffers from a rare ...
A teenager who lost her mother, aunt and uncle to a genetic condition has become the first person in Europe to receive a “life-changing” drug after it was approved for use on the NHS. Mary Catchpole, ...
Please provide your email address to receive an email when new articles are posted on . Every day, doctors across various specialties diagnose cases of inflammatory arthritis, enteropathy, ...
Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), an ultra-rare immunodeficiency ...
ANAVI Miracle Emitter is an open-source hardware ESP32-C3 WiFi and BLE controller designed to control 5V addressable RGB LED strips, which works with Home Assistant over MQTT and also supports the ...
The National Institute for Health and Care Excellence (NICE) has recommended Pharming’s Joenja (leniolisib) to treat patients with the ultra-rare immune disease, activated phosphoinositide 3-kinase ...
In final draft guidance published today, we have recommended leniolisib (also called Joenja and made by Pharming) for treating activated phosphoinositide 3-kinase delta syndrome (APDS), an ultra-rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback